Clinical Trial Update: Reactivating NK Cells in Treating Refractory Head and Neck Cancer [Phase 1, Phase 2]

View source ↗

Summary

A phase 1/2 trial investigating reactivation of natural killer (NK) cells for refractory head and neck cancers, including nasopharyngeal cancer and head and nec…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma
• Nasopharyngeal Cancer

Snippet

Sponsor: National University Hospital, Singapore | Conditions: Nasopharyngeal Cancer, Head and Neck Squamous Cell Carcinoma | Phase 1, Phase 2 | Status: UNKNOWN